Literature DB >> 14678272

Mushroom plant workers experience a shift towards a T helper type 2 dominant state: contribution of innate immunity to spore antigen.

T Saikai1, H Tanaka, N Sato, S Abe, A Matsuura.   

Abstract

Contemporary mushroom factories are places where there is a substantial risk of the occurrence of respiratory allergy. The aims of this investigation were to estimate its causative agents and to evaluate the contribution of innate immune response in mushroom workers who cultivate Hypsizigus marmoreus (Bunashimeji). Cross-sectional and follow-up studies were performed in the factory. We investigated CD1b, CD3, CD4, CD8, CD14, CD45RO, CD62L and CD161 expression in peripheral blood mononuclear cells (PBMC) by flow cytometry, and serum levels of interleukin (IL-2), IL-4, granulocyte-macrophage colony stimulating factor (GM-CSF), IL-13 and interferon (IFN)-gamma by enzyme-linked immunosorbent assay (ELISA). Co-culture experiments of PBMC with spore extracts were also performed. Percentages of CD1b+ monocytes, natural killer (NK), NK T and CD4+ T cells were increased in the workers compared with controls. Increases in Th2 type cells, Th2/Th1 ratio and serum IL-13 and decreased IFN-gamma were detected, indicating a Th2-biased status of the workers. The follow-up study showed that monocytes and NK cells increased soon after employment while CD4+ T, Th2 and NK T cells increased gradually as employment time lengthened. Serum precipitating antibody to the mushroom antigen could be detected at a later stage. Co-cultivation of PBMC with the spore extracts induced much higher CD1b expression, and suppressed secretion of Th1 cytokine in culture supernatants. These results indicate that the mushroom antigen contains highly immunogenic substances which stimulate PBMC into a Th2-biased in vivo status, and innate immune cells might also play a critical role in developing respiratory allergy in mushroom workers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678272      PMCID: PMC1808917          DOI: 10.1111/j.1365-2249.2004.02336.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells.

Authors:  D B Moody; B B Reinhold; M R Guy; E M Beckman; D E Frederique; S T Furlong; S Ye; V N Reinhold; P A Sieling; R L Modlin; G S Besra; S A Porcelli
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

2.  Interleukin-13 and interleukin-4 are coexpressed in atopic asthma.

Authors:  T C Kotsimbos; P Ernst; Q A Hamid
Journal:  Proc Assoc Am Physicians       Date:  1996-09

3.  IL-3 in combination with IL-4, induces the expression of functional CD1 molecules on monocytes.

Authors:  H Thomssen; M Kahan; M Londei
Journal:  Cytokine       Date:  1996-06       Impact factor: 3.861

4.  Basidiomycete mycelia and spore-allergen extracts: skin test reactivity in adults with symptoms of respiratory allergy.

Authors:  S B Lehrer; M Lopez; B T Butcher; J Olson; M Reed; J E Salvaggio
Journal:  J Allergy Clin Immunol       Date:  1986-09       Impact factor: 10.793

5.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; K Motoki; H Ueno; R Nakagawa; H Sato; E Kondo; H Koseki; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

Review 6.  The CD1 family: a third lineage of antigen-presenting molecules.

Authors:  S A Porcelli
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

Review 7.  The negative tuberculin test. Tuberculin, HIV, and anergy panels.

Authors:  E L Pesanti
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

8.  CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen.

Authors:  S Porcelli; C T Morita; M B Brenner
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

9.  IL-13 expression at the sites of allergen challenge in patients with asthma.

Authors:  S K Huang; H Q Xiao; J Kleine-Tebbe; G Paciotti; D G Marsh; L M Lichtenstein; M C Liu
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

10.  CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor.

Authors:  W Kasinrerk; T Baumruker; O Majdic; W Knapp; H Stockinger
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.